Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review.

Napuri, Norka I; Curcio, Daniel; Swerdlow, David L; Srivastava, Amit

Napuri, Norka I; Curcio, Daniel; Swerdlow, David L; Srivastava, Amit.

Afiliación

Napuri NI; Pfizer Vaccines, Lima, Peru.
Curcio D; Pfizer Vaccines, Madrid, Spain.
Swerdlow DL; Pfizer Vaccines, Collegeville, PA, USA.
Srivastava A; Vaccines, Medical Development, Scientific and Clinical Affairs, Pfizer Inc, 300 Technology Square, 3rd Floor, Cambridge, MA, 02139, USA. Amit.K.Srivastava@pfizer.com.

Infect Dis Ther ; 11(4): 1391-1414, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35614299

Palabras clave

COVID-19; COVID-19 vaccines; Chronic inflammatory disease; Hemodialysis; Human immunodeficiency virus; Immunocompromised individuals; Immunogenicity; Malignancy; SARS-CoV-2; Solid organ transplant recipients

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Infect Dis Ther Año: 2022 Tipo del documento: Article País de afiliación: Perú

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google